-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Werewolf Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Werewolf Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.6M, a 34.8% increase year-over-year.
- Werewolf Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $8.88M, a 12.1% increase year-over-year.
- Werewolf Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.01M, a 8.22% increase from 2022.
- Werewolf Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.4M, a 80.7% increase from 2021.
- Werewolf Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.1M, a 548% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)